Zantac® & Cancer Lawsuit
NDMA, a cancer-causing substance, has been linked to Zantac
Financial Compensation May Be Available Through a Zantac Lawsuit for Individuals Diagnosed with Any of the Following Types of Cancers:
- Bladder Cancer
- Esophageal Cancer
- Gastric Cancer
- Liver Cancer
- Pancreatic Cancer
- Stomach Cancer
We are currently reviewing potential class action lawsuits and individual cases for Zantac Users diagnosed with Cancer. According to allegations being presented, the pharmaceutical companies manufacturing Zantac have:
- Failed to Properly Research the Side Effects of Zantac Before Introducing the Drug.
- Knew or should have Discovered That Zantac Exposes Users to Unsafe Levels of the Carcinogen NDMA.
- Failed to Give Warning About Zantac’s Possible Link to Cancer.
- Failed to Promptly Issue Zantac Recalls or Safety Warnings for Users and the Medical Community.
Criteria for Lawsuit Review:
- Use Zantac, Zantac OTC or Generic Ranitidine
- Exposure to the Medication for at Least 3 Months; AND Diagnosed with Bladder Cancer, Stomach Cancer, Small Intestine Cancer, Colorectal Cancer, Esophageal Cancer or Other Digestive Tract Cancers
Zantac (Ranitidine) and High Levels of Cancer Causing Chemical
Side effects of Zantac may have exposed users to high levels of the Cancer-causing chemical N-Nitroso dimethylamine (NDMA).
Lawsuits are being reviewed nationwide for individuals meeting the criteria and who are suffering from Cancer.
Zantac was first introduced in 1983, as the first member of a new drug class of medication, known as histamine H2-receptor antagonists (H2 blockers).
Zantac was widely marketed and used as a safe treatment for heartburn, acid indigestion, sour stomach, Gastroesophageal Reflux Disease (GERD) and other conditions.
NOW, it appears that the side effects from Zantac may carry a much more serious risk of Cancer.
Find out if you or a loved one may be entitled to a Zantac settlement for a cancer diagnosis that may have been avoided by using a different heartburn medication.
Following Exposure for Only a Few Months, Experts Indicate That NDMA May Result in the Development of Cancer from ZANTAC/RANITIDINE.
Individuals Have the Right to Know the Facts About the Cancer Risks Associated with Zantac!
According to the Insurance Research Council, Injured Persons Who Hire Attorneys Receive 40% Higher Settlements on Average.
We Are Dedicated and Compassionate Professionals Who Care About your Wellbeing, Our Team Has Successfully Represented Zantac Cancer Cases.
